Our goal was to report our institutional experience with recombinant factor VIIa for the treatment and/or prevention of bleeding in nonhemophiliac children.
Abiomed Inc. said on Wednesday that it is slowing patient enrollment in a clinical trial of its AbioCor implantable self-contained mechanical heart […]
